ReviveMed

Revive Med

Biotechnology, 245 1st St, Cambridge, , 2142, Massachusetts, United States, 1-10 Employees

revive-med.com

  • LinkedIn

Who is REVIVEMED

ReviveMed, is an MIT spinout, AI-based metabolomic platform for precision medicine. Metabolites, small molecules such as glucose and cholesterol, offer crucial insights into disease, pati...

Read More

map
  • 245 1st St, Cambridge, Massachusetts, 2142, United States Headquarters: 245 1st St, Cambridge, Massachusetts, 2142, United States
  • 2018 Date Founded: 2018
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7372 | NAICS Code: 513210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from REVIVEMED

ReviveMed Org Chart and Mapping

Employees

Similar Companies to ReviveMed

Atomwise

  • 51-200 51-200
  • 25 Million to 50 Million $ 25 Million to 50 Million

Envisagenics

  • 11-50 11-50
  • 5 Million to 10 Million $ 5 Million to 10 Million

insitro

  • 201-500 201-500
  • 1 Million to 5 Million $ 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ReviveMed

Answer: ReviveMed's headquarters are located at 245 1st St, Cambridge, , 2142, Massachusetts, United States

Answer: ReviveMed's official website is https://revive-med.com

Answer: ReviveMed's revenue is $1 Million to $5 Million

Answer: ReviveMed's SIC: 7372

Answer: ReviveMed's NAICS: 513210

Answer: ReviveMed has 1-10 employees

Answer: ReviveMed is in Biotechnology

Answer: ReviveMed top competitors include: Atomwise , Envisagenics , insitro

Answer: ReviveMed contact info: Phone number: Website: https://revive-med.com

Answer: ReviveMed, is an MIT spinout, AI-based metabolomic platform for precision medicine. Metabolites, small molecules such as glucose and cholesterol, offer crucial insights into disease, patient physiology, and immune system activity, but current platforms can only detect less than 5% of human metabolites, hindering biological discoveries. We have developed the most advanced AI models capable of identifying more than 10,000 metabolite signals per patient, providing 20 times more data than any other platform. This wealth of data facilitates novel biological discoveries, which were not possible before. ReviveMed partners with pharma companies while also concentrating on internal programs focused on immune-metabolic disorders.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access